Apyx Medical Corporation (APYX) has formally filed its third quarter 2026 results for the period ended September 30, 2026. The 8-K filing serves as the official announcement of operations and financial condition, confirming the results were released to the public on November 5, 2026, although the primary filing shell did not include the full numerical press release text.
Key Highlights
- Official reporting of financial results for the third quarter of fiscal year 2026.
- Reporting period for the furnished results concluded on September 30, 2026.
- Management focus remains on the Surgical Aesthetics segment and the adoption of Renuvion and AYON technologies.